Tech Company Financing Transactions

Arcellx Funding Round

Arcellx closed a $85 million Series B funding round on 10/4/2019. Backers included AJU IB Investment, Quan Capital and Clough Capital Partners.

Transaction Overview

Company Name
Announced On
10/4/2019
Transaction Type
Venture Equity
Amount
$85,000,000
Round
Series B
Proceeds Purpose
Proceeds will be used to advance the Company's ARC-T + sparX programs, including clinical development of a bivalent BCMA-targeted cell therapy in multiple myeloma, and a CD123-targeted therapy in acute myeloid leukemia.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25 West Watkins Mill Rd. A
Gaithersburg, MD 20878
USA
Phone
Undisclosed
Email Address
Overview
Arcellx is a privately held biopharmaceutical company located in Montgomery County, Maryland. The Arcellx team is devoted to providing patients with superior immune cell therapies through scientific innovation, accelerated development, and responsible patient care.
Profile
Arcellx LinkedIn Company Profile
Social Media
Arcellx Company Twitter Account
Company News
Arcellx News
Facebook
Arcellx on Facebook
YouTube
Arcellx on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Rami Elghandour
  Rami Elghandour LinkedIn Profile  Rami Elghandour Twitter Account  Rami Elghandour News  Rami Elghandour on Facebook
Chief Financial Officer
Han Lee
  Han Lee LinkedIn Profile  Han Lee Twitter Account  Han Lee News  Han Lee on Facebook
Chief Medical Officer
Angela Shen
  Angela Shen LinkedIn Profile  Angela Shen Twitter Account  Angela Shen News  Angela Shen on Facebook
Chief Operating Officer
Michael Dombeck
  Michael Dombeck LinkedIn Profile  Michael Dombeck Twitter Account  Michael Dombeck News  Michael Dombeck on Facebook
Chief Technical Officer
David Hilbert
  David Hilbert LinkedIn Profile  David Hilbert Twitter Account  David Hilbert News  David Hilbert on Facebook
Vice President
Shashi Kaithamana
  Shashi Kaithamana LinkedIn Profile  Shashi Kaithamana Twitter Account  Shashi Kaithamana News  Shashi Kaithamana on Facebook
Vice President
Brian Murphy
  Brian Murphy LinkedIn Profile  Brian Murphy Twitter Account  Brian Murphy News  Brian Murphy on Facebook
VP - Bus. Development
Neeraj Teotia
  Neeraj Teotia LinkedIn Profile  Neeraj Teotia Twitter Account  Neeraj Teotia News  Neeraj Teotia on Facebook
VP - R & D
David Tice
  David Tice LinkedIn Profile  David Tice Twitter Account  David Tice News  David Tice on Facebook
VP - Regulatory Affairs
Brad Gliner
  Brad Gliner LinkedIn Profile  Brad Gliner Twitter Account  Brad Gliner News  Brad Gliner on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/4/2019: NABsys venture capital transaction
Next: 10/4/2019: AmacaThera venture capital transaction

 

Share this article

 


About Database of VC Transactions

We report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary